Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5202985
Max Phase: Preclinical
Molecular Formula: C48H86N18O7
Molecular Weight: 1027.33
Associated Items:
ID: ALA5202985
Max Phase: Preclinical
Molecular Formula: C48H86N18O7
Molecular Weight: 1027.33
Associated Items:
Canonical SMILES: CC(C)(C)[C@@H]1NC(=O)[C@H](CCCNC(N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCCNC(=O)CCN2CCN(CCC(=O)NCCCC[C@@H](C(=O)NCc3ccc(C(=N)N)cc3)NC1=O)CC2
Standard InChI: InChI=1S/C48H86N18O7/c1-48(2,3)39-45(73)63-34(42(70)60-30-31-14-16-32(17-15-31)40(50)51)11-5-7-21-57-38(68)19-25-66-28-26-65(27-29-66)24-18-37(67)56-20-6-4-10-33(49)41(69)61-35(12-8-22-58-46(52)53)43(71)62-36(44(72)64-39)13-9-23-59-47(54)55/h14-17,33-36,39,47,59H,4-13,18-30,49,54-55H2,1-3H3,(H3,50,51)(H,56,67)(H,57,68)(H,60,70)(H,61,69)(H,62,71)(H,63,73)(H,64,72)(H4,52,53,58)/t33-,34-,35-,36-,39+/m0/s1
Standard InChI Key: OELWYKHUGZGEGR-NXIBUDQUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1027.33 | Molecular Weight (Monoisotopic): 1026.6927 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Osman EEA, Rehemtulla A, Neamati N.. (2022) Why All the Fury over Furin?, 65 (4.0): [PMID:34340303] [10.1021/acs.jmedchem.1c00518] |
Source(1):